Drug-pricing reform legislation is stuck in Washington gridlock, but the Centers for Medicare and Medicaid Services is pushing forward reforms that could slash many seniors’ prescription-drug costs as soon as next year.
While drug-pricing reform legislation is stuck in Washington gridlock, a federal regulator is pushing forward reforms that could slash many seniors’ prescription-drug costs as soon as next year.
“It’s about time,” Antonio Ciaccia, CEO of drug-pricing research nonprofit 46brooklyn Research, said of the proposal. The pharmacy price concession issue, he says, “has been one of the festering wounds” within the Medicare Part D prescription-drug benefit. — Antonio Ciaccia, CEO of 46brooklyn Research Under the price-concession arrangements, negotiated between pharmacies and Part D plan sponsors or their PBMs, the amounts recouped from pharmacies after the point of sale are often tied to certain performance metrics, such as patients’ medication adherence.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Medicare proposes only covering Alzheimer's drug Aduhelm for clinical trial patientsBiogen drug, the first in decades approved to treat the disease, has sparked concerns about its high cost and efficacy.
Lire la suite »
7 Proven Steps to Forming Habits That LastFinding your deeper motivation is key to sticking with a new goal. Here's how it works, writes DrEvanParks
Lire la suite »
Medicare to Pay for Biogen’s New Alzheimer’s Drug in Clinical-Trial PatientsThe Centers for Medicare and Medicaid Services said it will cover the cost of the drug Aduhelm, but as part of further clinical testing.
Lire la suite »
Calm's New Daily Move Sessions Help Me Relax in the Most Original WaysOur editor tried the entire library of Calm's Daily Move sessions and found these 3 to be her favorites.
Lire la suite »
Stock Market Normality Returns, and It HurtsThe three ways that the market seems to be returning to normal after its pandemic unruliness, plus one possible change in its long-term pattern.
Lire la suite »
The New Scream Knows What You're Expecting and Surprises You AnywayThe fifth film in the horror franchise brings everything back to its roots, in more ways than one.
Lire la suite »